本页面由Tiger Trade Technology Pte. Ltd.提供服务

Puma Biotechnology Inc

10.29
+0.32003.21%
盘后:10.500.2100+2.04%19:58 EDT
成交量:30.31万
成交额:310.01万
市值:5.31亿
市盈率:20.43
高:10.36
开:9.96
低:9.85
收:9.97
52周最高:10.36
52周最低:4.58
股本:5,162.01万
流通股本:4,196.53万
量比:0.84
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):0.5036
每股收益(LYR):0.6100
净资产收益率:21.97%
总资产收益率:9.81%
市净率:3.83
市盈率(LYR):16.87

数据加载中...

2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

重要事件披露

8-K - Current report
2023/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals